KOVAI

Kovai Medical Center & Hospital Limited

Kovai Medical Center & Hospital Limited (KOVAI) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Hospital

kmchhospitals.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹5973.00
Market cap
6,536 Cr
Stock P/E
25.5
P/B
4.95
Dividend yield
0.2%
ROE (FY18)
20.1%
ROCE (FY18)
22.6%
Operating margin (FY18)
16.0%
Debt / equity (FY18)
0.57
OCF / EBITDA (FY26)
82.4%
OCF / EBITDA (3Y)
90.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Kovai Medical Center & Hospital Limited is classified in this platform under the Hospital industry leaf, reporting on an "industrial" statement basis as of the period ended December 31, 2025.

Company snapshot

15thBy market cap

Ranked among 24 companies in Hospital.

What we see

Positives
  • ✓91% of operating profit came in as cash over the last three years — profits are backed by real cash.
1 more signal from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales303 Cr321 Cr321 Cr315 Cr344 Cr355 Cr357 Cr374 Cr392 Cr407 Cr414 Cr431 Cr
Operating expenses (approx.)217 Cr225 Cr229 Cr229 Cr248 Cr252 Cr256 Cr268 Cr285 Cr291 Cr303 Cr307 Cr
EBITDA85 Cr96 Cr92 Cr86 Cr96 Cr103 Cr101 Cr106 Cr107 Cr116 Cr111 Cr124 Cr
OPM %28.2%30.0%28.5%27.4%27.8%29.0%28.3%28.3%27.3%28.5%26.8%28.7%
Other income4 Cr5 Cr6 Cr5 Cr5 Cr6 Cr6 Cr6 Cr6 Cr7 Cr8 Cr7 Cr
Interest8 Cr7 Cr7 Cr7 Cr8 Cr9 Cr9 Cr9 Cr9 Cr8 Cr6 Cr8 Cr
Depreciation23 Cr23 Cr24 Cr24 Cr24 Cr25 Cr25 Cr26 Cr27 Cr28 Cr29 Cr32 Cr
Profit before tax58 Cr71 Cr67 Cr61 Cr67 Cr75 Cr74 Cr76 Cr78 Cr87 Cr84 Cr92 Cr
Tax %25.7%24.7%22.0%24.6%24.8%23.1%26.4%25.1%24.4%25.4%24.8%24.5%
Net profit43 Cr53 Cr52 Cr46 Cr51 Cr58 Cr55 Cr57 Cr59 Cr65 Cr63 Cr69 Cr
EPS (₹)₹39.67₹48.52₹47.68₹41.81₹46.32₹52.83₹49.99₹52.30₹53.79₹59.42₹57.90₹63.14

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales531 Cr592 Cr628 Cr712 Cr690 Cr906 Cr1,019 Cr1,220 Cr1,371 Cr1,586 CrSign in free for the trailing twelve months
Operating expenses (approx.)406 Cr464 Cr495 Cr544 Cr497 Cr648 Cr751 Cr878 Cr985 Cr1,147 CrSign in free for the trailing twelve months
EBITDA125 Cr129 Cr132 Cr168 Cr193 Cr258 Cr267 Cr342 Cr386 Cr439 CrSign in free for the trailing twelve months
OPM %23.5%21.7%21.1%23.6%28.0%28.4%26.2%28.0%28.1%27.7%Sign in free for the trailing twelve months
Other income6 Cr8 Cr8 Cr11 Cr12 Cr12 Cr17 Cr21 Cr22 Cr28 CrSign in free for the trailing twelve months
Interest15 Cr13 Cr12 Cr15 Cr31 Cr43 Cr40 Cr33 Cr33 Cr32 CrSign in free for the trailing twelve months
Depreciation24 Cr34 Cr36 Cr52 Cr68 Cr85 Cr89 Cr92 Cr98 Cr109 CrSign in free for the trailing twelve months
Profit before tax92 Cr89 Cr93 Cr112 Cr106 Cr141 Cr155 Cr238 Cr278 Cr326 CrSign in free for the trailing twelve months
Tax %35.0%35.2%35.2%15.5%26.5%25.9%25.4%24.3%24.7%24.9%Sign in free for the trailing twelve months
Net profit60 Cr58 Cr60 Cr95 Cr78 Cr104 Cr116 Cr180 Cr209 Cr244 CrSign in free for the trailing twelve months
EPS (₹)₹54.81₹52.98₹54.96₹86.44₹71.00₹95.28₹105.80₹164.25₹190.95₹223.41Sign in free for the trailing twelve months
Dividend payout %————0.2%3.2%5.7%6.1%5.1%4.5%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital11 Cr11 Cr11 Cr11 Cr11 Cr11 Cr11 Cr11 Cr11 Cr11 Cr
Reserves224 Cr279 Cr332 Cr420 Cr499 Cr598 Cr708 Cr878 Cr1,075 Cr1,308 Cr
Borrowings90 Cr165 Cr345 Cr508 Cr559 Cr511 Cr473 Cr274 Cr382 Cr369 Cr
Other liabilities139 Cr153 Cr161 Cr168 Cr212 Cr222 Cr250 Cr275 Cr332 Cr378 Cr
Total liabilities464 Cr608 Cr850 Cr1,107 Cr1,281 Cr1,343 Cr1,442 Cr1,438 Cr1,800 Cr2,066 Cr
Fixed assets (net)354 Cr439 Cr468 Cr614 Cr994 Cr1,048 Cr1,086 Cr1,116 Cr1,279 Cr1,465 Cr
CWIP6 Cr13 Cr227 Cr300 Cr45 Cr5 Cr23 Cr39 Cr150 Cr135 Cr
Investments4 Cr4 Cr0.24 Cr0.12 Cr0.16 Cr0.20 Cr0.26 Cr0.45 Cr0.34 Cr0.52 Cr
Inventories9 Cr11 Cr10 Cr13 Cr10 Cr13 Cr14 Cr15 Cr16 Cr20 Cr
Trade receivables12 Cr14 Cr10 Cr8 Cr11 Cr19 Cr25 Cr17 Cr31 Cr38 Cr
Cash & bank17 Cr24 Cr27 Cr32 Cr7 Cr5 Cr18 Cr60 Cr14 Cr64 Cr
Other assets63 Cr103 Cr107 Cr141 Cr214 Cr251 Cr276 Cr192 Cr310 Cr343 Cr
Total assets464 Cr608 Cr850 Cr1,107 Cr1,281 Cr1,343 Cr1,442 Cr1,438 Cr1,800 Cr2,066 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity99 Cr87 Cr120 Cr166 Cr186 Cr263 Cr263 Cr344 Cr353 Cr362 Cr
Cash from investing-32 Cr-123 Cr-270 Cr-268 Cr-180 Cr-99 Cr-127 Cr-138 Cr-352 Cr-230 Cr
Cash from financing-50 Cr60 Cr160 Cr113 Cr38 Cr-120 Cr-86 Cr-243 Cr62 Cr-58 Cr
Net cash flow17 Cr24 Cr9 Cr11 Cr44 Cr44 Cr50 Cr-38 Cr63 Cr73 Cr
Free cash flow (OCF − Capex)63 Cr-42 Cr-157 Cr-102 Cr5 Cr163 Cr136 Cr206 Cr-0.18 Cr110 Cr

Ratios

MetricMar 2017Mar 2018
ROCE %33.1%22.6%
ROE %25.7%20.1%
Debtor days88
Inventory days2023
Days payable3743
Cash conversion cycle-9-11
OCF / EBITDA %79.3%67.3%
Debt / equity0.390.57
Current ratio0.951.15
Net debt / EBITDA0.581.09